In Vitro Characterization of Vilazodone as a Dual-Acting Serotonin Reuptake Inhibitor and 5-HT1A Receptor Partial Agonist

被引：0
|
作者：
Kehne, John H. [1 ]
Bartoszyk, Gerd D. [2 ]
Greiner, Hartmut E. [2 ]
Pierz, Kerri A. [3 ]
Renda, Matthew J. [3 ]
van Amsterdam, Christoph [2 ]
Reed, Carol R. [3 ]
Athanasiou, Maria C. [3 ]
机构：
[1] Translat Neuropharmacol Consulting LLC, Execut, Rockville, MD USA
[2] Merck KGaA, Preclin Pharmaceut Res, Darmstadt, Germany
[3] PGxHealth LLC, Div Clin Data, Med Affairs, New Haven, CT USA
来源：
BIOLOGICAL PSYCHIATRY | 2010年 / 67卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
821
引用
收藏
页码：237S / 237S
页数：1
相关论文
共 50 条
  • [41] A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
    Canale, Vittorio
    Grychowska, Katarzyna
    Kurczab, Rafal
    Ryng, Mateusz
    Keeri, Abdul Raheem
    Satala, Grzegorz
    Olejarz-Maciej, Agnieszka
    Koczurkiewicz, Paulina
    Drop, Marcin
    Blicharz, Klaudia
    Piska, Kamil
    Pekala, Elzbieta
    Janiszewska, Paulina
    Krawczyk, Martyna
    Walczak, Maria
    Chaumont-Dubel, Severine
    Bojarski, Andrzej J.
    Marin, Philippe
    Popik, Piotr
    Zajdel, Pawel
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [42] Neuronal Phenotype Dependency of Agonist-Induced Internalization of the 5-HT1A Serotonin Receptor
    Bouaziz, Elodie
    Emerit, Michel Boris
    Vodjdani, Guilan
    Gautheron, Vanessa
    Hamon, Michel
    Darmon, Michele
    Masson, Justine
    JOURNAL OF NEUROSCIENCE, 2014, 34 (01): : 282 - 294
  • [43] A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties
    Laban, U
    Kurrasch-Orbaugh, D
    Marona-Lewicka, D
    Nichols, DE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (06) : 793 - 795
  • [44] The serotonin 5-HT1A receptor agonist tandospirone improves executive function in common marmosets
    Baba, Satoko
    Murai, Takeshi
    Nakako, Tomokazu
    Enomoto, Takeshi
    Ono, Michiko
    Shimizu, Isao
    Ikeda, Kazuhito
    BEHAVIOURAL BRAIN RESEARCH, 2015, 287 : 120 - 126
  • [45] Synthesis of Dihydrofuroaporphine Derivatives: Identification of a Potent and Selective Serotonin 5-HT1A Receptor Agonist
    Liu, Zhili
    Zhang, Hai
    Ye, Na
    Zhang, Jing
    Wu, QianQian
    Sun, Peihua
    Li, Linyong
    Zhen, Xuechu
    Zhang, Ao
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (03) : 1319 - 1328
  • [46] Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity
    Venkatesan, Aranapakam M.
    Dos Santos, O.
    Ellingboe, John
    Evrard, Deborah A.
    Harrison, Boyd L.
    Smith, Deborah L.
    Scerni, Rosemary
    Hornby, Geoffrey A.
    Schechter, Lee E.
    Andree, Terrence H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 824 - 827
  • [47] Aripiprazole is a potent partial agonist at 5-HT1A receptors
    Jordan, S
    McQuade, RD
    Koprivica, V
    Chen, R
    Tottori, K
    Kikuchi, T
    Altar, CA
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 189 - 190
  • [48] Efficacy of a 5-HT1A partial agonist in atopic dermatitis
    Kawana, S.
    Kato, Y.
    Shimoda, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S40 - S40
  • [49] Aripiprazole is a potent partial agonist at 5-HT1A receptors
    Jordan, S
    McQuade, RD
    Koprivica, V
    Chen, R
    Tottori, K
    Kikuchi, T
    Altar, CA
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A17 - A17
  • [50] Lu-AA-21004. 5-HT3/7 receptor antagonist, 5-HT1A receptor agonist, 5-HT1B receptor partial agonist, 5-HT transporter inhibitor, Treatment of depression, Treatment of anxiety
    Haddley, K.
    DRUGS OF THE FUTURE, 2011, 36 (08) : 577 - 584
12345